Literature DB >> 35931882

Predictors of Peak Expiratory Cough Flow in Individuals with Amyotrophic Lateral Sclerosis.

Lauren Tabor Gray1,2, Kasey L McElheny3, Terrie Vasilopoulos4, James Wymer5, Barbara K Smith6, Emily K Plowman3,5,7.   

Abstract

Dystussia is prevalent in individuals with amyotrophic lateral sclerosis (ALS), leading to a diminished physiologic capacity to effectively defend the airway. We aimed to identify predictors of peak expiratory cough flow rate in individuals with ALS. One hundred and thirty-four individuals with a confirmed diagnosis of ALS (El-Escorial criteria revised) completed the ALS Functional Rating Scale-Revised (ALSFRS-R) and underwent pulmonary function and cough spirometry testing. Pearson's correlation coefficients and hierarchical multiple regression modeling were conducted to determine predictors of voluntary cough peak expiratory flow rate (p < 0.05). The full model including age, bulbar disease, cough spirometry metrics, and respiratory parameters had a marginal R2 = 0.635, F (7, 126) = 30.241, p < 0.0005, adjusted R2 = 0.61. Maximum expiratory pressure, compression phase, and vital capacity did not contribute and were therefore removed (p < 0.05). The most parsimonious predictive model included age, bulbar disease, peak inspiratory flow rate and duration, peak expiratory rise time, and inspiratory pressure generation with a marginal R2 = 0.543. Although expiratory pressure generation has historically served as the therapeutic target to improve dystussia in ALS, the current dataset highlighted that the inability to quickly and forcefully inspire during the inspiratory phase of voluntary cough places patients at a mechanical disadvantage to generate subsequent high-velocity expiratory airflow to clear the airway. Thus, therapeutic training programs that include both inspiratory and expiratory strength targets may optimize airway clearance capacity in this challenging patient population.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Airway protection; Cough; Deglutition; Neurodegenerative

Year:  2022        PMID: 35931882     DOI: 10.1007/s00455-022-10503-8

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   2.733


  32 in total

1.  Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial.

Authors:  Emily K Plowman; Lauren Tabor-Gray; K Michelle Rosado; Terrie Vasilopoulos; Raele Robison; Jennifer L Chapin; Joy Gaziano; Tuan Vu; Clifton Gooch
Journal:  Muscle Nerve       Date:  2018-11-29       Impact factor: 3.217

2.  Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.

Authors:  Michael I Polkey; Rebecca A Lyall; Ke Yang; Erin Johnson; P Nigel Leigh; John Moxham
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

3.  Respiratory complications of amyotrophic lateral sclerosis.

Authors:  Joshua O Benditt
Journal:  Semin Respir Crit Care Med       Date:  2002-06       Impact factor: 3.119

4.  Relationship Between the Eating Assessment Tool-10 and Objective Clinical Ratings of Swallowing Function in Individuals with Head and Neck Cancer.

Authors:  Loni C Arrese; Ricardo Carrau; Emily K Plowman
Journal:  Dysphagia       Date:  2016-08-18       Impact factor: 3.438

Review 5.  Airway clearance techniques in neuromuscular disorders: A state of the art review.

Authors:  Michelle Chatwin; Michel Toussaint; Miguel R Gonçalves; Nicole Sheers; Uwe Mellies; Jesus Gonzales-Bermejo; Jesus Sancho; Brigitte Fauroux; Tiina Andersen; Brit Hov; Malin Nygren-Bonnier; Matthieu Lacombe; Kurt Pernet; Mike Kampelmacher; Christian Devaux; Kathy Kinnett; Daniel Sheehan; Fabrizio Rao; Marcello Villanova; David Berlowitz; Brenda M Morrow
Journal:  Respir Med       Date:  2018-02-06       Impact factor: 3.415

Review 6.  Ventilatory control in ALS.

Authors:  Nicole L Nichols; J Van Dyke; L Nashold; I Satriotomo; M Suzuki; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-18       Impact factor: 1.931

7.  Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis.

Authors:  Jesús Sancho; Emilio Servera; Juan Díaz; Julio Marín
Journal:  Am J Respir Crit Care Med       Date:  2007-04-05       Impact factor: 21.405

8.  Respiratory measurements and airway clearance device prescription over one year in amyotrophic lateral sclerosis.

Authors:  R Tattersall; D Murray; M Heverin; J Rooney; K Tobin; R Vance; O Hardiman; D Meldrum
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-12-11       Impact factor: 4.092

9.  The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis.

Authors:  T B M Tilanus; J T Groothuis; J M C TenBroek-Pastoor; T B Feuth; Y F Heijdra; J P L Slenders; J Doorduin; B G Van Engelen; M J Kampelmacher; J Raaphorst
Journal:  Respir Res       Date:  2017-07-25

10.  Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management.

Authors:  Emanuela Onesti; Ilenia Schettino; Maria Cristina Gori; Vittorio Frasca; Marco Ceccanti; Chiara Cambieri; Giovanni Ruoppolo; Maurizio Inghilleri
Journal:  Front Neurol       Date:  2017-03-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.